Gravity Diagnostics: An In-Network Provider with All MCOs in Kentucky!
Gravity Diagnostics is proud to be an in-network provider with all Managed Care Organizations (MCOs) in the state of Kentucky, including WellCare, Anthem, Aetna, Humana, Molina, and UnitedHealthcare. This underscores our commitment to ensuring high-quality diagnostic services are accessible to everyone in our community. Enhanced Access to Care As an in-network provider, we…
Read More2024 National Drug Threat Assessment and Gravity Diagnostics’ Trending Data
Authors: Nicholas Lyktey, Chief of Laboratory Operations, and Jordan Kelsey, Clinical Product Specialist The Drug Enforcement Administration (DEA) released the 2024 National Drug Threat Assessment, which contains a comprehensive assessment of illicit drug threats and traffic trends in the United States. Gravity Diagnostics’ Team continues to be proactively educated on new drug trends and add…
Read MoreKentucky Biomarker Bill: The Right Test for the Right Treatment
Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) The right test for the right treatment. The Commonwealth of Kentucky enacted HB180 this year which mandates insurance coverage of biomarker testing. Kentucky joins 13 other states with legislation addressing this complex issue. Biomarkers can either be direct targets or closely associated indicators of a disease. …
Read MorePGx: Truth, Hope, and Hype
Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Pharmacogenetics (PGx) is the practice of applying the knowledge of an individual’s genes to guide the best therapeutic options. Given the generality of this definition, there are numerous ways to implement PGx in practice. In this article, we’ll cover the basics of PGx, detailing what it is and…
Read MoreXylazine: Still a Threat
Author: Dr. JP Canner, Ph.D., NRCC, MT(AAB) Xylazine: Still a Threat In April 2023, Xylazine was designated as an emerging threat to the United States after a series of reports from the FDA (Food and Drug Administration) and DEA (Drug Enforcement Administration). (1) While the dangers of Xylazine have been documented, the prevalence of…
Read MoreGravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety
[[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a significant expansion of their testing services. They are now offering comprehensive testing for Xylazine, a powerful sedative and muscle relaxant. This groundbreaking addition to their testing portfolio demonstrates their unwavering commitment to advancing public health and safety. Xylazine, originally…
Read More5 Tips to Manage Stress
May is Mental Health Awareness Month and making sure that you’re taking care of your emotional well-being is a vital part of one’s overall health. Mental health includes our emotional, psychological, and social well-being. It affects how you think, feel, and act. It also helps determine how you handle stress Stress is a natural and…
Read MoreGravity Diagnostics Partners with Film Cincinnati to Provide COVID-19 Testing
EY Announces Tony Remington and Julie Brazil of Gravity Diagnostics as an Entrepreneur Of The Year® 2021 East Central Award Winner
COVINGTON, KY- Ernst & Young LLP (EY US) announced yesterday that Tony Remington, CEO, and Julie Brazil, COO, of Gravity Diagnostics were named an Entrepreneur Of The Year® 2021 East Central Award winner. The Entrepreneur Of The Year Awards program is one of the preeminent competitive awards for entrepreneurs and leaders of high-growth companies. The award recognizes those who…
Read MoreGravity Diagnostics Sponsors Blood Drive with Hoxworth Blood Center and the University of Cincinnati
COVINGTON, KY – Gravity Diagnostics partnered with the Hoxworth Blood Center, a division of the University of Cincinnati, to host a blood drive in Covington, Kentucky. On July 8th, 56 Gravity employees took time out of their busy schedules to donate blood. Of the employees, 26 were first-time donors, a reminder that these events spearhead…
Read More